CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 19 enrolled
Drug / intervention
Amoxicillin-Potassium Clavulanate Combination +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02258763
NCT02258763Phase 4Completed

Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life

University of Malaya·interventional·Posted Oct 7, 2014·Updated Apr 23, 2019

In Brief

A Phase 4 clinical trial evaluating Amoxicillin-Potassium Clavulanate Combination and Placebo for Pneumonia. Completed, enrolled 19 participants across 1 site.

Detailed Summary

To determine, in children hospitalized with pneumonia, if an extended duration of oral antibiotics (10 days) will be superior to a shorter duration (3 days) of antibiotics in improving clinical outcomes. Secondary Aims: 1. Describe the prevalence of respiratory viruses and bacteria at presentation. 2. Investigate the depression, anxiety and stress scores (DASS21) and quality of life scored (QOL) by parents of the children during admission, pre-discharge and post discharge and at follow-ups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesMalaysia

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 7, 2014
Enrollment StartNov 1, 2014
Primary CompletionNov 1, 2017
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 11.7 years ago

Interventions

Amoxicillin-Potassium Clavulanate Combinationdrug

Oral antibiotic for 10 days

Placebodrug

Placebo made to look like the study drug-main ingredient sugar syrup made by the pharmacy department in the hospital In the placebo arm, patient will be given 3 days of antibiotic followed by 7 days of placebo